MSI-H/DMMR COLORECTAL CANCER
Clinical trials for MSI-H/DMMR COLORECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new MSI-H/DMMR COLORECTAL CANCER trials appear
Sign up with your email to follow new studies for MSI-H/DMMR COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to shrink colon tumors before surgery, possibly replacing chemo
Disease control Recruiting nowThis phase 3 trial tests whether the immunotherapy drug AK104 (Cadonilimab) given before and after surgery works better than standard chemotherapy for people with a specific type of colon cancer (MSI-H/dMMR). About 386 adults with stage II or III colon cancer that can be removed …
Matched conditions: MSI-H/DMMR COLORECTAL CANCER
Phase: PHASE3 • Sponsor: Akeso • Aim: Disease control
Last updated May 26, 2026 08:23 UTC
-
New hope for Hard-to-Treat cancers: experimental drug combo enters human trials
Disease control Recruiting nowThis study tests an experimental drug called EIK1005, alone or with another drug (pembrolizumab), in people with advanced solid tumors that have not responded to other treatments. The goal is to find a safe dose and see if the combination can shrink tumors. About 160 adults with …
Matched conditions: MSI-H/DMMR COLORECTAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Eikon Therapeutics • Aim: Disease control
Last updated May 22, 2026 14:02 UTC